This Week on MoneyTV with Donald Baillargeon, 10/1
HOLLYWOOD, CA / ACCESSWIRE / October 1, 2021 / Mr. Olympia, self-driving cars, veterans’ rights,…
HOLLYWOOD, CA / ACCESSWIRE / October 1, 2021 / Mr. Olympia, self-driving cars, veterans’ rights,…
– Non-Fungible Token (NFT) sale will be launched this fall with an exceptional advisory board–…
Founder of SAMR Inc., Albert Boufarah provides his list of sustainable everyday solutions to help…
The Baltimore-area dental practice franchise wishes to call the public’s attention to one of the…
GÖTEBORG, SE / ACCESSWIRE / October 1, 2021 / Smart Eye (STO:SEYE)(OTC PINK:SMTEF)(FRA:SE9) Smart Eye…
London – October 1st 2021 – The UK Cyber Security Council – the charitable, self-regulatory…
RUSH.GG redefines platforms in gaming and esports RUSH.GG is set to become in gaming and…
Second Phase 2 trial initiated from BioNTech’s proprietary individualized mRNA-based cancer vaccine platform iNeST Randomized…
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, October 1, 2021 : SIX Exchange…
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company…
Preliminary clinical data from Phase 1/2 study still anticipated in Q4 SAN MATEO, Calif. and…
CAMBRIDGE, Mass. and NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
HOUSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical…
SAN DIEGO, Sept. 30, 2021 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics (NASDAQ: EFTR), a leader in…
Company to host conference call and webcast Thursday, October 7, 2021, at 9:00 a.m. ET…
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology…
Management to host webcast and conference call on October 7 at 8 a.m. ET SAN…
The KN-8701 trial is a multi-center, open-label, two-part trial of Kinnate’s lead RAF inhibitor candidate…
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) — Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company…
Cloud-based and validated regulatory software automates and advances quality of patient narratives PRINCETON, N.J., Sept….